Pharmaceutical, biopharmaceutical, and medical device companies looking to enter the Latin American pharmaceutical markets must leverage global strategies to develop products efficiently, expedite market access, and maximize return on investment. Underestimating the product development and regulatory complexities of the Latin American region in constant political and regulatory evolution can severely hamper the reaches of a regional commercial strategy, compromising abundant opportunities in a region with the fastest pharmaceutical commercial growth.
At Axis HealthCare we work to develop sound regional product development and portfolio strategies that leverage regional and local specialized expertise in-country resources to gain the competitive advantage essential to commercial success. Axis HealthCare supports clients to ensure the most optimal regional product development approach with emphasis on the development of the regulatory and clinical strategies.
Axis HealthCare is able to provide your company pertinent regional data, assessment, and insights to accelerate product development by minimizing hurdles of regulatory and clinical development. Our strategy design allows for country access as well as for quick expansion into new markets in the region through effective regulatory partnering in the country to drive efficiency and pipeline productivity while maintaining low cost. For example, for clinical trials, we ensure a seamless regulatory process and speed of patient recruitment, while assuring lower clinical trial costs. This is supported by a full complement of customized country / region strategies to guarantee regulatory compliance, and to minimize the risk of product failures or regulatory rejections.
The regional team includes an extensive team of proven regulatory and healthcare professionals based in key countries such as Argentina, Brazil, Colombia, and Mexico. This positions Axis HealthCare as a regional industry leader in strategic product development in the Latin American Region.